FDA Clearance Tracker · P160053
MagtraceTM and Sentimag(R) Magnetic Locatization System
Last checked: Nov 20, 2026Latest source record: Jul 24, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jul 24, 2018
Approved
Time to decision
601 days
Received Nov 30, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P160053
- Device name
- MagtraceTM and Sentimag(R) Magnetic Locatization System
- Applicant
- Endomagnetics Ltd.,
- Applicant location
- Cambridge
- Received
- Nov 30, 2016
- Decided
- Jul 24, 2018
- Decision
- Approved
- Supplements
- 10 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- General & Plastic Surgery
FDA's approval statement
As written in FDA's record.
Approval for the MagtraceTM and Sentimag® Magnetic Localization System. The MagtraceTM and Sentimag® Magnetic Localization System is indicated to assist in localizing lymph nodes draining a tumor site, as part of a sentinel lymph node biopsy procedure, in patients with breast cancer undergoing a mastectomy. MagtraceTM is intended and calibrated for use ONLY with the Sentimag® system.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PUV (Lymph node location system during sentinel biopsy procedure).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Endomagnetics Ltd.,
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232865 · Decided Jun 28, 2024 · 287 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.